MARKET

ZSQR

ZSQR

Coeptis Therapeutics Inc
NASDAQ
15.20
-1.20
-7.32%
After Hours: 15.15 -0.05 -0.33% 18:11 04/27 EDT
OPEN
18.80
PREV CLOSE
16.40
HIGH
18.80
LOW
9.00
VOLUME
200.76K
TURNOVER
--
52 WEEK HIGH
21.41
52 WEEK LOW
6.80
MARKET CAP
94.59M
P/E (TTM)
-5.4014
1D
5D
1M
3M
1Y
5Y
1D
*News On Coeptis Therapeutics Holdings Inc. (COEP) Now Under ZSQR
Dow Jones · 8h ago
Weekly Report: what happened at COEP last week (0420-0424)?
Weekly Report · 19h ago
Coeptis Completes Merger, Rebrands as Z Squared Inc.
TipRanks · 3d ago
*Z Squared Announces Completion of Business Combination With Coeptis Therapeutics
Dow Jones · 3d ago
Coeptis-Z Squared business combination closes, shares set to trade as ZSQR on Nasdaq
PUBT · 3d ago
Weekly Report: what happened at COEP last week (0413-0417)?
Weekly Report · 04/20 10:11
Weekly Report: what happened at COEP last week (0406-0410)?
Weekly Report · 04/13 10:15
Coeptis Wins Nasdaq Nod for Z Squared Merger Listing
TipRanks · 04/08 10:32
More
About ZSQR
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical and technology company. The Company is focused on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its segments are Biotechnology and Technology. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed by the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and robotic process automation capabilities. The Company’s subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.

Webull offers Coeptis Therapeutics Holdings Inc stock information, including NASDAQ: ZSQR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZSQR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZSQR stock methods without spending real money on the virtual paper trading platform.